WEE1 inhibition targets cell cycle checkpoints for triple negative breast cancers to overcome cisplatin resistance

Cisplatin is one of the most commonly used therapeutic drugs for cancer therapy, yet prolonged cisplatin treatment frequently results in drug resistance. To enhance therapeutic effect of cisplatin, we conducted a high throughput screening using a kinase library containing 704 kinases against triple...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Hongping, Shao, Fangyuan, Martin, Scots, Xu, Xiaoling, Deng, Chu-Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338009/
https://www.ncbi.nlm.nih.gov/pubmed/28262781
http://dx.doi.org/10.1038/srep43517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338009/
https://www.ncbi.nlm.nih.gov/pubmed/28262781
http://dx.doi.org/10.1038/srep43517

Ejemplares similares